November 16, 2018
Welcome to our weekly roundup of pharmacy articles, blog posts, and stories from across the web.
Every week we share our favorite articles that other organizations, associations, and companies are producing to help your pharmacy business thrive.
You’ll discover new strategies and tips to boost your independent community pharmacy business and to stay up-to-date on what’s happening in the pharmacy industry.
This week we chose five articles covering topics from the efficacy of popular supplements to creating eye-catching endcap displays.
In an effort to reduce opioid-related deaths, many states and municipalities have eliminated legal obstacles to obtaining Naxolone. Yet Stat News reports that few pharmacies are keeping the overdose-reversal drug in stock.
After long-awaited research revealed disappointing conclusions about Vitamin D and fish oil, patients wondered if they should keep taking the popular supplements. NPR invited experts, including a leading researcher on the study, to weigh in.
You can gorge yourself on Turkey Day but don’t overdo it when it comes to marketing spending. Digital Pharmacist shares tips for eliminating inefficient advertising and focusing on the highest return on investment.
Xofluza, the first new influenza drug in 20 years, hits shelves soon. Drug Topics explains how its advent will affect Tamiflu sales this year.
Endcaps are prime real estate for your front end. Hamacher Resource Group details how to create effective endcap displays based on specific health needs.
Want more pharmacy business tips and advice? Sign up for our e-newsletter.